Syndros is a prescription medication that contains the active ingredient dronabinol, which is a synthetic form of tetrahydrocannabinol (THC), the main psychoactive component of cannabis. It is approved by the FDA for the treatment of anorexia associated with weight loss in patients with AIDS, as well as nausea and vomiting caused by chemotherapy in cancer patients who have not responded to conventional antiemetic treatments.

Syndros works by interacting with the body’s endocannabinoid system, which plays a role in regulating appetite, mood, and nausea. By mimicking the effects of THC, Syndros can help stimulate appetite in patients with AIDS-related anorexia and reduce nausea and vomiting in chemotherapy patients.

It is important to note that Syndros is a controlled substance and has the potential for abuse and dependence. It should only be used under the supervision of a healthcare provider who is experienced in prescribing medications for the conditions it is approved to treat.

Common side effects of Syndros may include dizziness, drowsiness, confusion, and changes in mood. It is important to report any side effects to your healthcare provider so they can monitor your response to the medication and make any necessary adjustments to your treatment plan.

If you are considering using Syndros, it is important to discuss the risks and benefits with your healthcare provider to determine if it is the right treatment option for you. As with any medication, it is important to follow your healthcare provider’s instructions for use and to report any concerns or side effects promptly.